• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黏多糖贮积症的肌肉骨骼表现。

Musculoskeletal manifestations of mucopolysaccharidoses.

机构信息

Division of Rheumatology, Department of Pediatrics, British Columbia's Children's Hospital, 4480 Oak Street, Vancouver, BC V6H 3V4, Canada.

出版信息

Rheumatology (Oxford). 2011 Dec;50 Suppl 5:v19-25. doi: 10.1093/rheumatology/ker397.

DOI:10.1093/rheumatology/ker397
PMID:22210666
Abstract

The mucopolysaccharidoses (MPSs) are a heterogeneous group of inherited metabolic disorders caused by enzyme deficiencies that lead to progressive lysosomal storage of glycosaminoglycans. Musculoskeletal manifestations are common across all forms of MPS and are often apparent early in the disease course. Diagnostic delays occur frequently in these patients, especially those with more attenuated forms of disease. Treatments for many types of MPS are now available; however, they are most effective if started early before the development of irreversible damage. Some manifestations such as stiffness and joint contractures may mimic other conditions such as inflammatory arthritis, which may cause further delays. Rheumatologists and other specialists should be aware of the musculoskeletal manifestations of MPS so that diagnostic delays can be avoided and appropriate management initiated.

摘要

黏多糖贮积症(MPS)是一组由酶缺乏引起的遗传性代谢紊乱,导致糖胺聚糖在溶酶体中进行性贮积。MPS 所有类型都有骨骼肌肉表现,且通常在疾病早期就表现明显。这些患者常出现诊断延迟,尤其是疾病表现较为轻微的患者。目前已有多种 MPS 的治疗方法,但如果在不可逆损伤发生前尽早开始治疗,效果最佳。某些表现,如僵硬和关节挛缩,可能类似于其他疾病,如炎性关节炎,这可能会导致进一步的延迟。风湿病学家和其他专家应了解 MPS 的骨骼肌肉表现,以避免诊断延迟并开始进行适当的治疗。

相似文献

1
Musculoskeletal manifestations of mucopolysaccharidoses.黏多糖贮积症的肌肉骨骼表现。
Rheumatology (Oxford). 2011 Dec;50 Suppl 5:v19-25. doi: 10.1093/rheumatology/ker397.
2
Overview of the mucopolysaccharidoses.黏多糖贮积症概述。
Rheumatology (Oxford). 2011 Dec;50 Suppl 5:v4-12. doi: 10.1093/rheumatology/ker394.
3
Mucopolysaccharidoses.黏多糖贮积症。
Curr Rheumatol Rep. 2014 Jan;16(1):389. doi: 10.1007/s11926-013-0389-0.
4
Musculoskeletal manifestations of lysosomal storage disorders.溶酶体贮积症的肌肉骨骼表现
Ann Rheum Dis. 2009 Nov;68(11):1659-65. doi: 10.1136/ard.2008.095315.
5
Mucopolysaccharidoses and other lysosomal storage diseases.黏多糖贮积症和其他溶酶体贮积症。
Rheum Dis Clin North Am. 2013 May;39(2):431-55. doi: 10.1016/j.rdc.2013.03.004.
6
Ocular manifestations as key features for diagnosing mucopolysaccharidoses.眼部表现作为诊断黏多糖贮积症的关键特征。
Rheumatology (Oxford). 2011 Dec;50 Suppl 5:v34-40. doi: 10.1093/rheumatology/ker392.
7
The mucopolysaccharidoses: advances in medical care lead to challenges in orthopaedic surgical care.黏多糖贮积症:医疗护理的进步给骨科手术护理带来挑战。
Bone Joint J. 2017 Sep;99-B(9):1132-1139. doi: 10.1302/0301-620X.99B9.BJJ-2017-0487.
8
Osteoimmunology in mucopolysaccharidoses type I, II, VI and VII. Immunological regulation of the osteoarticular system in the course of metabolic inflammation.黏多糖贮积症 I、II、VI 和 VII 型的骨免疫学。代谢性炎症过程中骨关节系统的免疫调节。
Osteoarthritis Cartilage. 2013 Dec;21(12):1813-23. doi: 10.1016/j.joca.2013.08.001. Epub 2013 Aug 13.
9
Orthopaedic aspects of mucopolysaccharidoses.黏多糖贮积症的矫形外科问题。
Rheumatology (Oxford). 2011 Dec;50 Suppl 5:v26-33. doi: 10.1093/rheumatology/ker393.
10
Diagnosis of the mucopolysaccharidoses.黏多糖贮积症的诊断。
Rheumatology (Oxford). 2011 Dec;50 Suppl 5:v41-8. doi: 10.1093/rheumatology/ker390.

引用本文的文献

1
The ESCRT protein CHMP5 restricts bone formation by controlling endolysosome-mitochondrion-mediated cell senescence.内体分选转运复合体(ESCRT)蛋白CHMP5通过控制内溶酶体-线粒体介导的细胞衰老来限制骨形成。
Elife. 2025 Jul 7;13:RP101984. doi: 10.7554/eLife.101984.
2
Systematic Analysis of Multiple Imaging Modalities in Infants Diagnosed with Mucopolysaccharidosis by Newborn Screening.通过新生儿筛查诊断为黏多糖贮积症的婴儿的多种成像模态的系统分析
Diagnostics (Basel). 2025 Apr 12;15(8):980. doi: 10.3390/diagnostics15080980.
3
Review of clinical trials and guidelines for children and youth with mucopolysaccharidosis: outcome selection and measurement.
儿童和青少年黏多糖贮积症的临床试验和指南综述:结局选择和测量。
Orphanet J Rare Dis. 2024 Oct 23;19(1):393. doi: 10.1186/s13023-024-03364-x.
4
Macrocephaly and Finger Changes: A Narrative Review.大头畸形和手指改变:一篇叙述性综述。
Int J Mol Sci. 2024 May 20;25(10):5567. doi: 10.3390/ijms25105567.
5
Beyond pGALS: the need for a multifaceted musculoskeletal decision-making tool ('pGALSplus') in community-based clinical practice.超越pGALS:在社区临床实践中需要一种多方面的肌肉骨骼决策工具(“pGALSplus”)
Rheumatol Adv Pract. 2024 Jan 23;8(1):rkae004. doi: 10.1093/rap/rkae004. eCollection 2024.
6
Molecular Mechanisms in Pathophysiology of Mucopolysaccharidosis and Prospects for Innovative Therapy.黏多糖贮积症病理生理学中的分子机制和创新治疗的前景。
Int J Mol Sci. 2024 Jan 17;25(2):1113. doi: 10.3390/ijms25021113.
7
Femoral Structure and Biomechanical Characteristics in Sanfilippo Syndrome Type-B Mice.Sanfilippo 综合征 B 型小鼠的股骨结构和生物力学特征。
Int J Mol Sci. 2023 Sep 12;24(18):13988. doi: 10.3390/ijms241813988.
8
Mucopolysaccharidosis Type VI with Recurrent Chest Infection.伴有反复胸部感染的VI型黏多糖贮积症
Cureus. 2023 Feb 20;15(2):e35229. doi: 10.7759/cureus.35229. eCollection 2023 Feb.
9
Proteomics identifies novel biomarkers of synovial joint disease in a canine model of mucopolysaccharidosis I.蛋白质组学鉴定黏多糖贮积症 I 犬模型中滑膜关节疾病的新型生物标志物。
Mol Genet Metab. 2023 Feb;138(2):107371. doi: 10.1016/j.ymgme.2023.107371. Epub 2023 Jan 4.
10
Mucopolysaccharidosis: What Pediatric Rheumatologists and Orthopedics Need to Know.黏多糖贮积症:儿科风湿病学家和骨科医生需要了解的内容。
Diagnostics (Basel). 2022 Dec 27;13(1):75. doi: 10.3390/diagnostics13010075.